Beyond, Inc. (NYSE:BYON) shares are moving Monday, and the stock is up more than 9% over the past month. Here’s a look at what to know.
What To Know:
Needham analyst Anna Andreeva on Friday upgraded Beyond from Hold to Buy and announced a $40 price target. According to a report from Barrons, Needham sees the potential for the company to reduce or eliminate some fixed expenses and is encouraged by Lemonis at the helm of the company.
Andreeva’s price target of $40 represents a nearly 56% potential upside for the stock.
It should also be noted that 12.53% of available Beyond shares are being sold short, according to data from Benzinga Pro.
Related News: What’s Going On With BioCryst Pharmaceuticals Stock?
BYON Price Action: According to Benzinga Pro, Beyond shares are up 1.3% at $25.67 at the time of publication.
Image: Gentelle_Linen from Pixabay
